Concentrations of Erlotinib in Tumor Tissue and Plasma in Non-Small-Cell Lung Cancer Patients After Neoadjuvant Therapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Works matching IS 15257304 AND DT 2015 AND VI 16 AND IP 4
Results: 15
1
2
Association of Wnt-Inducible Signaling Pathway Protein 1 Genetic Polymorphisms With Lung Cancer Susceptibility and Platinum-Based Chemotherapy Response.
- Published in:
- 2015
- By:
- Publication type:
- journal article
3
Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
4
Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non-Small-Cell Lung Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
5
Current and Future Approaches in the Management of Non-Small-Cell Lung Cancer Patients With Resistance to EGFR TKIs.
- Published in:
- 2015
- By:
- Publication type:
- journal article
6
Concentrations of Erlotinib in Tumor Tissue and Plasma in Non--Small-Cell Lung Cancer Patients After Neoadjuvant Therapy.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 4, p. 320, doi. 10.1016/j.cllc.2014.12.012
- By:
- Publication type:
- Article
7
Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 4, p. 313, doi. 10.1016/j.cllc.2014.12.006
- By:
- Publication type:
- Article
8
Cardiovascular Comorbidities and Events in NSCLC: Often Underestimated but Worth Considering.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 4, p. 305, doi. 10.1016/j.cllc.2014.12.007
- By:
- Publication type:
- Article
9
Association of Wnt-Inclucible Signaling Pathway Protein 1 Genetic Polymorphisms With Lung Cancer Susceptibility and Platinum-Based Chemotherapy Response.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 4, p. 298, doi. 10.1016/j.cllc.2014.12.008
- By:
- Publication type:
- Article
10
Improving the Care of Patients With Stage IB Non--Small-Cell Lung Cancer: Role of Prognostic Signatures and Use of Cell Cycle Progression Biomarkers.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 4, p. 245, doi. 10.1016/j.cllc.2015.02.008
- By:
- Publication type:
- Article
11
Prophylactic Cranial Irradiation for Patients With Locally Advanced Non--Small-Cell Lung Cancer at High Risk for Brain Metastases.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 4, p. 292, doi. 10.1016/j.cllc.2014.11.005
- By:
- Publication type:
- Article
12
Current and Future Approaches in the Management of Non--Small-Cell Lung Cancer Patients With Resistance to EGFR TKIs.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 4, p. 252, doi. 10.1016/j.cllc.2014.12.013
- By:
- Publication type:
- Article
13
Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 4, p. 282, doi. 10.1016/j.cllc.2014.12.003
- By:
- Publication type:
- Article
14
Relationship Among Gefitinib Exposure, Polymorphisms of Its Metabolizing Enzymes and Transporters, and Side Effects in Japanese Patients With Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 4, p. 274, doi. 10.1016/j.cllc.2014.12.004
- By:
- Publication type:
- Article
15
Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/ Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 4, p. 262, doi. 10.1016/j.cllc.2014.12.002
- By:
- Publication type:
- Article